Turja Chakrabarti • UCSF Profiles

Turja Chakrabarti, MD

Title(s)	Assistant Professor, Medicine
School	School of Medicine
Address	521 Parnassus Avenue San Francisco CA 94143
Phone	--
vCard	Download vCard

Biography

Education and Training

Johns Hopkins Bayview Medical Center, Baltimore, MD		06/2021	Internal Medicine Chief Residency
Johns Hopkins Bayview Medical Center, Baltimore, MD		06/2020	Internal Medicine Residency
Eastern Virginia Medical School, Norfolk, VA	MD	05/2017	Doctor of Medicine
Georgetown University, Washington D.C.	MS	05/2013	Physiology & Biophysics
University of Pennsylvania, Philadelphia, PA	BA	05/2012	Global Health & Societies

Awards and Honors

Johns Hopkins University School of Medicine	2020	Alpha Omega Alpha Medical Honor Society
Johns Hopkins University School of Medicine	2020	Larry Waterbury MD Award for resident clinical excellence
Eastern Virginia Medical School	2016	Gold Humanism Honor Society

Overview

Dr. Chakrabarti serves as faculty within the UCSF Division of Hospital Medicine, with a primary clinical role on the Hematology-Oncology-BMT Hospitalist Service.

His research interests focus on novel therapies for lung cancer. Specifically, he is investigating mechanisms to overcome resistance to targeted therapies in patients with oncogene mutations in lung cancer such as EGFR.

In addition, he is the President & Founder of Pratit International, an organization dedicated to bridging global health disparities with a special focus on vulnerable communities in Kolkata, India.

Interests

lung cancer, EGFR mutation, Global Health

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC. Cancer Discov. 2023 Apr 17. Negrao MV, Araujo HA, Lamberti G, Cooper AJ, Akhave NS, Zhou T, Delasos L, Hicks JK, Aldea M, Minuti G, Hines J, Aredo JV, Dennis MJ, Chakrabarti T, Scott SC, Bironzo P, Scheffler M, Christopoulos P, Stenzinger A, Riess JW, Kim SY, Goldberg SB, Li M, Wang Q, Qing Y, Ni Y, Do MT, Lee R, Ricciuti B, Alessi JV, Wang J, Resuli B, Landi L, Tseng SC, Nishino M, Digumarthy SR, Rinsurongkawong W, Rinsurongkawong V, Vaporciyan AA, Blumenschein GR, Zhang J, Owen DH, Blakely CM, Mountzios G, Shu CA, Bestvina CM, Garassino MC, Marrone KA, Gray JE, Patel SP, Cummings AL, Wakelee HA, Wolf J, Scagliotti GV, Cappuzzo F, Barlesi F, Patil PD, Drusbosky L, Gibbons DL, Meric-Bernstam F, Lee JJ, Heymach JV, Hong DS, Heist RS, Awad MM, Skoulidis F. PMID: 37068173.

View in: PubMed Mentions: Fields:
Neo Neoplasms
Association of severe lymphopenia and disease progression in unresectable locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapy. Lung Cancer. 2021 04; 154:36-43. Friedes C, Chakrabarti T, Olson S, Prichett L, Brahmer JR, Forde PM, Voong RK, Marrone KA, Lam VK, Hann CL, Broderick SR, Battafarano RJ, Ha JS, Bush EL, Yang SC, Hales RK, Feliciano JL. PMID: 33611224.

View in: PubMed Mentions: 13 Fields:
Neo Neoplasms
Translation:Humans